Logo-SpeeDx.png

A PCR innovator in search of an interpretation solution

"Customers would sometimes question whether a result is real if the amplification looked inefficient or late. FastFinder removes the need for this eyes-on interpretation and reduces analysis time."

Litty Tan, Director of R&D at SpeeDx

header.jpg

SpeeDx

Founded in 2009 in Sydney, SpeeDx’ current IVD portfolio consists of two multiplex assays: ResistancePlus™ MG and PlexPCR™  HSV-1&2, VZV. The company is also developing a pipeline of multiplex assays including those for Respiratory viruses; HSV-1&2, VZV & Syphilis and STI panels.

goals.png

Goals

  • Overcoming the challenge and time-consuming process of result interpretation

  • Defining assay-specific results: sometimes amplification means more than just detection

  • Clearing the pathway to support customer questions about certain results

obstacles.png

Obstacles

  • In-house, spreadsheet-based interpretation software required manual manipulation of raw data and had limited security features

  • Manual copy-paste of raw data created potential for human errors

  • Supporting customers often involved back-and-forth mailing of result files

results.png

Results

  • Completely validated, device-independent and artificially intelligent PCR result interpretation software

  • A secure, standardized & audit-trailed workflow with little to no margin for user error

  • Support is always just a click away, a fully trained SpeeDx team can help customers where they need it the most

"Rapid turnaround"

No laborious software projects

“The plug-and-play foundation of FastFinder enabled fast turnaround of our software product. Although it is a generic software, the team attempted to incorporate our feedback into the development process." Litty Tan, R&D Director at SpeeDx.

box-2.png

A turnkey solution

CE-IVD compliant interpretation workflow.

Before, SpeeDx end-users would use industrial software for the interpretation and an MS Excel based analysis software to automate sample interpretation. However, the format wasn’t as user-friendly and still required some manual transferring of raw data.

Utrecht-Header.jpg

Don't take our word for it

Colin Denver

CEO at SpeeDx Ltd.

Since FastFinder is compatible with multiple PCR platforms, we don't have to tie ourselves to a single platform. This empowers us to expand our product offerings to more users and laboratories.

colindenver.jpg
background.jpg

Read the full case